Raiffeisen Bank International Ag Bluebird Bio, Inc. Transaction History
Raiffeisen Bank International Ag
- $6.6 Trillion
- Q4 2024
A detailed history of Raiffeisen Bank International Ag transactions in Bluebird Bio, Inc. stock. As of the latest transaction made, Raiffeisen Bank International Ag holds 112 shares of BLUE stock, worth $812. This represents 0.0% of its overall portfolio holdings.
Number of Shares
112Holding current value
$812% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding BLUE
# of Institutions
19Shares Held
20.3MCall Options Held
0Put Options Held
2K-
Black Rock Inc. New York, NY15.4MShares$112 Million0.0% of portfolio
-
Pictet Asset Management Sa Geneva 73, V84.67MShares$33.8 Million0.02% of portfolio
-
Colony Group LLC Boston, MA41.9KShares$304,0790.0% of portfolio
-
Connacht Asset Management LP New York, NY31.6KShares$229,3460.59% of portfolio
-
Raymond James Financial Services Advisors, Inc. St. Petersburg, FL28.7KShares$208,1470.0% of portfolio
About bluebird bio, Inc.
- Ticker BLUE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 77,121,800
- Market Cap $559M
- Description
- bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...